Svarstad B L, Chewning B A, Sleath B L, Claesson C
School of Pharmacy, University of Wisconsin-Madison, 425 No. Charter St., Madison, WI 53706, USA.
Patient Educ Couns. 1999 Jun;37(2):113-24. doi: 10.1016/s0738-3991(98)00107-4.
Self-report tools for monitoring adherence can be useful in identifying patients who need assistance with their medications, assessing patient concerns, and evaluating new programs. The aim of this study is to test the validity of the Brief Medication Questionnaire (BMQ), a new self-report tool for screening adherence and barriers to adherence. The tool includes a 5-item Regimen Screen that asks patients how they took each medication in the past week, a 2-item Belief Screen that asks about drug effects and bothersome features, and a 2-item Recall Screen about potential difficulties remembering. Validity was assessed in 20 patients using the Medication Events Monitoring System (MEMS). Results varied by type of non-adherence, with the Regimen and Belief Screens having 80-100% sensitivity for "repeat" non-adherence and the Recall Screen having 90% sensitivity for "sporadic" non-adherence. The BMQ appears more sensitive than existing tools and may be useful in identifying and diagnosing adherence problems.
用于监测依从性的自我报告工具在识别需要药物治疗帮助的患者、评估患者担忧以及评估新项目方面可能会很有用。本研究的目的是测试简短用药问卷（BMQ）的有效性，这是一种用于筛查依从性和依从性障碍的新的自我报告工具。该工具包括一个5项的用药方案筛查，询问患者过去一周每种药物的服用方式；一个2项的信念筛查，询问药物效果和令人烦恼的特征；以及一个2项的回忆筛查，关于记忆潜在困难。使用药物事件监测系统（MEMS）对20名患者进行了有效性评估。结果因不依从类型而异，用药方案和信念筛查对“重复”不依从的敏感性为80%-100%，回忆筛查对“偶尔”不依从的敏感性为90%。BMQ似乎比现有工具更敏感，可能有助于识别和诊断依从性问题。
